mewburn-logo-white mewburn-logo
  • About us
    • About us
    • Working with our Munich Office
    • Our AI Strategy & Action Plan
    • Who we work with
    • How we work with our clients
    • The Mewburn Ellis culture
    • Community giving
    • Inclusion & diversity
      • Inclusion & diversity
      • Gender Pay Gap
      • Women in IP
    • Sustainability
    • Join Mewburn Ellis
      • Join Mewburn Ellis
      • Vacancies
    • Graduate training programme
    • Business partners
      • Business partners
      • Code of conduct
      • Diversity policy
      • Environmental policy
  • Our People
    • Our People
    • View All People
    • Our Leadership Team
  • About you
    • Who we work with
    • I'm an attorney/law firm
    • I'm a university/R&D
    • I'm a corporate
    • I'm an SME
    • I'm a start up/spin out
  • Which service?
    • Services
    • I want to patent an invention
      • I want to patent an invention
      • Chemistry Patents
      • Engineering Patents
      • Life Sciences Patents
      • Patent Disputes
      • Patent Renewals
      • European Patent Validations
      • Pharma Patent Extensions & Regulatory Exclusivity
    • I want to protect a brand
      • I want to protect a brand
      • Register a trade mark
      • Trade mark disputes
      • Trade mark renewals
      • I want to change a domain name
    • I want to protect my design
      • Register a Design
      • Design Renewals
    • I need help with contentious proceedings
      • Contentious proceedings
      • post grant proceedings
      • oppositions or appeals
      • IP litigation or disputes
      • The Unified Patent Court
    • I need some commercial advice
    • I need to validate my European patent
    • I want to renew my ip rights
  • Spotlight on
    • Health
      • Advanced therapeutics
      • Animal health
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future food
      • Medical technologies
      • Microbiome
      • Pharmaceuticals
      • Plants
      • Precision medicine
      • Speciality pharma
    • Technology
      • Artificial Intelligence (AI)
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future mobility
      • Green & sustainable technologies
      • Medical technologies
      • New Nuclear Technologies
      • Quantum Technology
      • Software
      • Space Technology
    • Industry
      • 2d materials
      • Automotive
      • Energy storage
      • Green tech
      • Marine & ocean engineering
      • Medical devices
      • Polymers
      • Pharmaceuticals
      • Plants
      • Speciality pharma
      • Synthetic biology
    • Intellectual property
      • Brexit
      • Green ip
      • Ip litigation
      • Oppositions - chemistry & materials
      • Oppositions - engineering & ICT
      • Oppositions - life sciences
      • UPC
      • Women in ip
  • Knowledge hub
    • Law & practice library
    • News, insights & features
    • Special reports
    • Films
    • Events and Webinars
  • Contact us
    • Offices
      • 8 Bishopsgate
    • Residencies
  • en
  • zh-hans
  • germany
  • ja
  • ko
  • About us
    • About us
    • Working with our Munich Office
    • Our AI Strategy & Action Plan
    • Who we work with
    • How we work with our clients
    • The Mewburn Ellis culture
    • Community giving
    • Inclusion & diversity
      • Inclusion & diversity
      • Gender Pay Gap
      • Women in IP
    • Sustainability
    • Join Mewburn Ellis
      • Join Mewburn Ellis
      • Vacancies
    • Graduate training programme
    • Business partners
      • Business partners
      • Code of conduct
      • Diversity policy
      • Environmental policy
  • Our People
    • Our People
    • View All People
    • Our Leadership Team
  • About you
    • Who we work with
    • I'm an attorney/law firm
    • I'm a university/R&D
    • I'm a corporate
    • I'm an SME
    • I'm a start up/spin out
  • Which service?
    • Services
    • I want to patent an invention
      • I want to patent an invention
      • Chemistry Patents
      • Engineering Patents
      • Life Sciences Patents
      • Patent Disputes
      • Patent Renewals
      • European Patent Validations
      • Pharma Patent Extensions & Regulatory Exclusivity
    • I want to protect a brand
      • I want to protect a brand
      • Register a trade mark
      • Trade mark disputes
      • Trade mark renewals
      • I want to change a domain name
    • I want to protect my design
      • Register a Design
      • Design Renewals
    • I need help with contentious proceedings
      • Contentious proceedings
      • post grant proceedings
      • oppositions or appeals
      • IP litigation or disputes
      • The Unified Patent Court
    • I need some commercial advice
    • I need to validate my European patent
    • I want to renew my ip rights
  • Spotlight on
    • Health
      • Advanced therapeutics
      • Animal health
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future food
      • Medical technologies
      • Microbiome
      • Pharmaceuticals
      • Plants
      • Precision medicine
      • Speciality pharma
    • Technology
      • Artificial Intelligence (AI)
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future mobility
      • Green & sustainable technologies
      • Medical technologies
      • New Nuclear Technologies
      • Quantum Technology
      • Software
      • Space Technology
    • Industry
      • 2d materials
      • Automotive
      • Energy storage
      • Green tech
      • Marine & ocean engineering
      • Medical devices
      • Polymers
      • Pharmaceuticals
      • Plants
      • Speciality pharma
      • Synthetic biology
    • Intellectual property
      • Brexit
      • Green ip
      • Ip litigation
      • Oppositions - chemistry & materials
      • Oppositions - engineering & ICT
      • Oppositions - life sciences
      • UPC
      • Women in ip
  • Knowledge hub
    • Law & practice library
    • News, insights & features
    • Special reports
    • Films
    • Events and Webinars
  • Contact us
    • Offices
      • 8 Bishopsgate
    • Residencies
  • All topics
  • Forward
  • Artificial Intelligence
  • Battery Technologies
  • Bioinformatics
  • Brexit
  • Chemistry
  • Commercial Advice
  • Community
  • COVID-19
  • Designs
  • Energy Storage
  • Engineering
  • EU Unitary Patent / Unified Patent Court
  • FemTech
  • Future Food Tech
  • Future Mobility
  • Graphene & 2D Materials
  • Green Tech
  • ICT
  • Life Sciences
  • Litigation
  • Marine & Ocean Engineering
  • Materials
  • MedTech
  • Microbiome
  • Nature based materials
  • Nuclear
  • On-Demand
  • Oppositions
  • Patents
  • Pharmaceuticals
  • Plants
  • Polymers
  • Polymer recycling
  • Precision Medicine
  • Quantum Computing
  • SME
  • Software
  • Space Tech
  • Synthetic Biology
  • Trade Marks
Most opposed medical device companies at the EPO 2023
Tom Furnival - October 8, 2024

Most opposed medical device companies at the EPO 2023

Following on from our recent post on the Most Opposed Companies at the EPO 2023 we’ve broken that ...

The major players in the SEP landscape in Europe
Tom Furnival - February 14, 2024

The major players in the SEP landscape in Europe

Next in our series of blogs, we have investigated the major players in the SEP landscape in Europe.

How does declaring a patent or application as “essential to a standard” affect the pre-grant experience of an application? – Part 3
Tom Furnival - December 19, 2023

How does declaring a patent or application as “essential to a standard” affect the pre-grant experience of an application? – Part 3

This article continues our series of blogs investigating whether or not declaring your patent or ...

How does declaring a patent or application as “essential to a standard” affect the pre-grant experience of an application? – Part 2
Tom Furnival - September 20, 2023

How does declaring a patent or application as “essential to a standard” affect the pre-grant experience of an application? – Part 2

This article is the latest in a series of blogs exploring whether declaring your patent or ...

UPC as a forum for SEP disputes – Panasonic kick off proceedings
Tom Furnival - August 10, 2023

UPC as a forum for SEP disputes – Panasonic kick off proceedings

With the UPC opening its doors just over two months’ ago, the IP profession has been keenly ...

Mewburn Ellis ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent Practitioners 2023
Joanna Smith - July 4, 2023

Mewburn Ellis ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent Practitioners 2023

We are delighted to once again be ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent ...

Does declaring your patent or application as “essential to a standard” influence the outcome of that patent or application in Europe?
Tom Furnival - April 13, 2023

Does declaring your patent or application as “essential to a standard” influence the outcome of that patent or application in Europe?

This blog is the first in a series in which we explore standards essential patents using patent ...

Board of Appeal confirms DABUS AI cannot be an inventor for a European patent application
Tom Furnival - December 24, 2021

Board of Appeal confirms DABUS AI cannot be an inventor for a European patent application

On 21st December 2021 the EPO rejected the two appeals filed by Dr Thaler concerning whether an ...

Qualcomm unveils world's first 5G, AI-enabled, autonomous drone
Tom Furnival - September 24, 2021

Qualcomm unveils world's first 5G, AI-enabled, autonomous drone

In their latest offering, the Qualcomm Flight RB5 5G Platform, Qualcomm are cementing themselves as ...

We helped determine the meaning of “technical feature”
Stephen Gill - May 6, 2021

We helped determine the meaning of “technical feature”

Case - T 0258/03 Our extensive arguments in relation to whether a feature is ‘technical’ have ...

Ericsson accuses Samsung of un-FRAND-ly patent negotiations
Tom Furnival - December 17, 2020

Ericsson accuses Samsung of un-FRAND-ly patent negotiations

Following on from Unwired Planet v Huawei, Ericsson have launched a complaint in the US District ...

Mixed reality: Is it the blend that will boost human wellbeing?
Tom Furnival - October 6, 2020

Mixed reality: Is it the blend that will boost human wellbeing?

From simulating the evaluation of cardiovascular patients to turning CT scans into 3D holograms, ...

Unwired Planet v Huawei – the Supreme Court’s FRAND(ly) judgement
Tom Furnival - August 26, 2020

Unwired Planet v Huawei – the Supreme Court’s FRAND(ly) judgement

Published Wednesday 26th August 2020, the Supreme Court has handed down their long anticipated ...

A brighter future for unconventional agriculture?
Tom Furnival - July 28, 2020

A brighter future for unconventional agriculture?

At the cost of more than one sad-looking hanging basket, I have come to understand that plants ...

Mitsubishi Electric to embark on 5G testing programme
Tom Furnival - June 9, 2020

Mitsubishi Electric to embark on 5G testing programme

In a recent press release Mitsubishi Electric Corporation announced that Japan’s Ministry of ...

5G and autonomous vehicles - accelerating data communication speed
Tom Furnival - April 28, 2020

5G and autonomous vehicles - accelerating data communication speed

The amount of data that self-driving cars are predicted to use is massive, really massive. A study ...

How 3D printing is helping in the fight against coronavirus (COVID-19)
Tom Furnival - April 22, 2020

How 3D printing is helping in the fight against coronavirus (COVID-19)

In a crisis which has been defined by its pace of change, 3D printing has become a useful tool in ...

3D printing community responds to the coronavirus (COVID-19) challenge
Jacqueline Murphy - April 3, 2020

3D printing community responds to the coronavirus (COVID-19) challenge

The coronavirus (COVID19) pandemic has left healthcare systems globally scrambling for much needed ...

A case in point - Trunki vs Kiddee
Tom Furnival - August 7, 2019

A case in point - Trunki vs Kiddee

Rob Law, the founder and chief executive of Magmatic who make the Trunki product, said that the ...

EPO Quality Report 2018
Tom Furnival - July 12, 2019

EPO Quality Report 2018

July has seen the publishing of the European Patent Office’s (EPO) 2018 Quality Report. This is the ...

More

  • Slavery Act
  • Legal Notices
  • Terms and Conditions
  • Privacy
  • Forward Community Programme
  • Client Login
  • Join Mewburn Ellis

Follow us

Subscribe

Sign up to Forward: news, insights and features from Mewburn Ellis

Contact

  • mail@mewburn.com
  • London:

    +44 (0)20 7776 5300
  • Bristol:

    +44 (0)117 945 1234
  • Cambridge:

    +44 (0)1223 420383
  • Manchester:

    +44 (0)161 2477 722
  • Munich:

    +49 (0)89 244 459800

Copyright © 2025 Mewburn Ellis. All rights reserved. Terms and Conditions & Online Privacy